CART peptide inhibits locomotor activity induced by simultaneous stimulation of D1 and D2 receptors, but not by stimulation of individual dopamine receptors

Synapse

Volumn 65, Issue 1, 2011, Pages 1-7

  Moffett, Mark C ^a   Song, Jane ^a   Kuhar, Michael J ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

CART peptide; D1 D2 synergy; DA; DA receptors; Nucleus accumbens

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; QUINELORANE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL STUDY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STATISTICAL SIGNIFICANCE; STIMULATION; SYNAPSE;

ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE AGONISTS; MALE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEURONS; NUCLEUS ACCUMBENS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 78049411734     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20815     Document Type: Article

References (38)

1. Bachtell RK, Whisler K, Karanian D, Self DW. 2005. Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat. Psychopharmacology (Berl) 183: 41-53.
2. Braun AR, Chase TN. 1986. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. Eur J Pharmacol 131: 301-306.
3. Choi KH, Zarandi B, Todd KG, Biondo AM, Greenshaw AJ. 2000. Effects of AMPA/kainate receptor blockade on responses to dopamine receptor agonists in the core and shell of the rat nucleus accumbens. Psychopharmacology (Berl) 150: 102-111.
4. David HN, Abraini JH. 2001. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens. Neuropharmacology 41: 454-463.
5. David HN, Abraini JH. 2002. Group III metabotropic glutamate receptors and D1-like and D2-like dopamine receptors interact in the rat nucleus accumbens to influence locomotor activity. Eur J Neurosci. 15: 869-875.
6. David HN, Sissaoui K, Abraini JH. 2004. Modulation of the locomotor responses induced by D1-like and D2-like dopamine receptor agonists and D-amphetamine by NMDA and non-NMDA glutamate receptor agonists and antagonists in the core of the rat nucleus accumbens. Neuropharmacology 46: 179-191.
7. Deng YP, Lei WL, Reiner A. 2006. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J Chem Neuroanat 32: 101-116.
8. Douglass J, McKinzie AA, Couceyro P. 1995. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15: 2471-2481.
9. Hopf FW, Cascini MG, Gordon AS, Diamond I, Bonci A. 2003. Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein βγ subunits. J Neurosci 23: 5079-5087.
10. Hubert GW, Kuhar MJ. 2008. Cocaine administration increases the fraction of CART cells in the rat nucleus accumbens that co-immunostain for c-Fos. Neuropeptides 42: 339-343.
11. Hunter RG, Vicentic A, Rogge G, Kuhar MJ. 2005. The effects of cocaine on CART expression in the rat nucleus accumbens: A possible role for corticosterone. Eur J Pharmacol 517: 45-50.
12. Hunter RG, Jones D, Vicentic A, Hue G, Rye D, Kuhar MJ. 2006. Regulation of CART mRNA in the rat nucleus accumbens via D3 dopamine receptors. Neuropharmacology 50: 858-864.
13. Ikemoto S, Glazier BS, Murphy JM, McBride WJ. 1997. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J Neurosci 17: 8580-8587.
14. Ireland MD, Lowe AS, Reavill C, James MF, Leslie RA, Williams SC. 2005. Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging. Neuroscience 133: 315-326.
15. Jaworski JN, Jones DC. 2006. The role of CART in the reward/reinforcing properties of psychostimulants. Peptides 27: 1993-2004.
16. Jaworski JN, Kozel MA, Philpot KB, Kuhar MJ. 2003. Intra-accumbal injection of CART (cocaine-amphetamine regulated transcript) peptide reduces cocaine-induced locomotor activity. J Pharmacol Exp Ther 307: 1038-1044.
17. Jaworski JN, Kimmel HL, Mitrano DA, Tallarida RJ, Kuhar MJ. 2007. Intra-VTA CART 55-102 reduces the locomotor effect of systemic cocaine in rats: An isobolographic analysis. Neuropeptides 41: 65-72.
18. Jaworski JN, Hansen ST, Kuhar MJ, Mark GP. 2008. Injection of CART (cocaine- and amphetamine-regulated transcript) peptide into the nucleus accumbens reduces cocaine self-administration in rats. Behav Brain Res. 191: 266-271.
19. Kim JH, Creekmore E, Vezina P. 2003. Microinjection of CART peptide 55-102 into the nucleus accumbens blocks amphetamine-induced locomotion. Neuropeptides 37: 369-373.
20. Kim S, Yoon HS, Kim JH. 2007. CART peptide 55-102 microinjected into the nucleus accumbens inhibits the expression of behavioral sensitization by amphetamine. Regul Pept 144: 6-9.
21. Kimmel HL, Gong W, Vechia SD, Hunter RG, Kuhar MJ. 2000. Intra-ventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference. J Pharmacol Exp Ther 294: 784-792.
22. Kimmel HL, Thim L, Kuhar MJ. 2002. Activity of various CART peptides in changing locomotor activity in the rat. Neuropeptides 36: 9-12.
23. Koylu EO, Couceyro PR, Lambert PD, Kuhar MJ. 1998. Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J Comp Neurol. 391: 115-132.
24. Marie-Claire C, Laurendeau I, Canestrelli C, Courtin C, Vidaud M, Roques B, Noble F. 2003. Fos but not Cart (cocaine and amphetamine regulated transcript) is overexpressed by several drugs of abuse: A comparative study using real-time quantitative polymerase chain reaction in rat brain. Neurosci Lett 345: 77-80.
25. Meyer ME. 1993. Effects of intraaccumbens dopamine agonist SK&F38393 and antagonist SCH23390 on locomotor activities in rats. Pharmacol Biochem Behav 45: 843-847.
26. Meyer ME. 1996. Mesolimbic 7-OH-DPAT affects locomotor activities in rats. Pharmacol Biochem Behav 55: 209-214.
27. Meyer ME, Van Hartesveldt C, Potter TJ. 1993. Locomotor activity following intra-accumbens microinjections of dopamine D1 agonist SK&F 38393 in rats. Synapse 13: 310-314.
28. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. New York: Academic Press.
29. Robertson GS, Robertson HA. 1986. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats. Brain Res 384: 387-390.
30. Rogge G, Jones D, Hubert GW, Lin Y, Kuhar MJ. 2008. CART peptides: Regulators of body weight, reward and other functions. Nat Rev Neurosci 9: 747-758.
31. Rouillon C, Abraini JH, David HN. 2008a. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core. Exp Neurol 212: 213-217.
32. Rouillon C, Degoulet M, Chevallier K, Abraini JH, David HN. 2008b. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens. Brain Res 1198: 44-54.
33. So CH, Verma V, O'Dowd BF, George SR. 2007. Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor. Mol Pharmacol 72: 450-462.
34. Vrang N, Larsen PJ, Kristensen P. 2002. Cocaine-amphetamine regulated transcript (CART) expression is not regulated by amphetamine. Neuroreport 13: 1215-1218.
35. Wachtel SR, Hu XT, Galloway MP, White FJ. 1989. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Synapse 4: 327-346.
36. Walters JR, Bergstrom DA, Carlson JH, Chase TN, Braun AR. 1987. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science 236: 719-722.
37. White FJ. 1987. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist. Eur J Pharmacol 135: 101-105.
38. Yoon HS, Kim S, Park HK, Kim JH. 2007. Microinjection of CART peptide 55-102 into the nucleus accumbens blocks both the expression of behavioral sensitization and ERK phosphorylation by cocaine. Neuropharmacology 53: 344-351.